Ascoril Expectorant syrup bottle 100 ml

Ascoril Expectorant is a combined drug with bronchodilator, mucolytic and expectorant effects. Thanks to the rational combination of salbutamol, bromhexine hydrochloride, guaifenesin and menthol, it effectively and quickly reduces the severity of functional disorders of the respiratory system.

Salbutamol is a selective β2-adrenergic agonist _that effectively and for a long time dilates the bronchi. In therapeutic doses, it does not cause stimulation of cardiac activity.

Bromhexine hydrochloride reduces the viscosity of sputum and promotes its evacuation from the bronchi.

Guaifenesin promotes expectoration and secretion removal. Menthol reduces the severity of irritation and inflammation of the respiratory tract mucosa.

Respiratory tract diseases accompanied by the formation of viscous, difficult-to-separate secretions – tracheobronchitis, chronic obstructive bronchitis, bronchiectasis, pulmonary emphysema, pulmonary tuberculosis, pneumonia.

Adults and children over 12 years old – 10 ml (2 teaspoons) of syrup 3 times a day, children aged 6-12 years old – 5-10 ml (1-2 teaspoons) of syrup 3 times a day, 2-6 years old – 5 ml (1 teaspoon) of syrup 3 times a day. The duration of treatment is determined individually.

Hypersensitivity to salbutamol and other sympathomimetics, bromhexine, guaifenesin, menthol or other components of the drug, age up to 2 years.

The most common side effects associated with the use of salbutamol are: they do not differ from those for other β2-adrenergic agonists and include muscle tremor (mainly of the hands), painful muscle spasms. Sometimes, moderate tachycardia, anxiety, headache, and peripheral vasodilation may develop. In patients sensitive to the action of β2-adrenergic agonists, a compensatory increase in heart rate may develop against the background of a decrease in heart rate. Sometimes, when using Ascoril Expectorant, digestive tract disorders (nausea, vomiting, diarrhea, abdominal pain) may develop, which are associated with the effects of guaifenesin, bromhexine hydrochloride, and menthol.

Some patients may develop a transient increase in the activity of aminotransferases in the blood caused by bromhexine.

It is prescribed with caution for hyperthyroidism, diabetes mellitus, diseases of the cardiovascular system (CHD, angina pectoris, arrhythmia) and gastric or duodenal ulcer.

The safety of the drug during pregnancy or breastfeeding has not been sufficiently documented, therefore, when prescribing the drug to these categories of patients, the benefits obtained from using the drug should be carefully weighed against the potential risk to the fetus or infant. Breastfeeding is recommended to be discontinued during the use of the drug.

While taking the drug, it is better to refrain from driving and other activities that require precise coordination, speed of reaction, and concentration.

Hypokalemia, which develops as a result of the use of drugs containing salbutamol, may be exacerbated by the simultaneous administration of diuretics. As a result, the risk of developing arrhythmias increases when using cardiac glycosides against the background of such treatment.

The severity of the effects of salbutamol may be reduced with the simultaneous use of β-adrenergic blockers, especially non-selective ones (propranolol), and may also increase with the simultaneous use of xanthines (theophylline).

In case of overdose, agitation, confusion and respiratory depression may develop. Treatment is symptomatic.

In a dry, dark place at a temperature not exceeding 25 °C.